196 related articles for article (PubMed ID: 34642897)
1. Identification of a Suitable Untargeted Agent for the Clinical Translation of ABY-029 Paired-Agent Imaging in Fluorescence-Guided Surgery.
Wang C; Xu X; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):97-109. PubMed ID: 34642897
[TBL] [Abstract][Full Text] [Related]
2. Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols.
Wang C; Xu X; Folaron M; Gunn JR; Hodge S; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):110-121. PubMed ID: 34651290
[TBL] [Abstract][Full Text] [Related]
3. Paired-agent imaging for detection of head and neck cancers.
Samkoe KS; Park Y; Marra K; Chen EY; Tichauer KM
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10853():. PubMed ID: 31686720
[TBL] [Abstract][Full Text] [Related]
4. Rapid and Quantitative Intraoperative Pathology-Assisted Surgery by Paired-Agent Imaging-Derived Confidence Map.
Wang C; Hodge S; Ravi D; Chen EY; Hoopes PJ; Tichauer KM; Samkoe KS
Mol Imaging Biol; 2023 Feb; 25(1):190-202. PubMed ID: 36315374
[TBL] [Abstract][Full Text] [Related]
5. Preclinical imaging of epidermal growth factor receptor with ABY-029 in soft-tissue sarcoma for fluorescence-guided surgery and tumor detection.
Samkoe KS; Sardar HS; Bates BD; Tselepidakis NN; Gunn JR; Hoffer-Hawlik KA; Feldwisch J; Pogue BW; Paulsen KD; Henderson ER
J Surg Oncol; 2019 Jun; 119(8):1077-1086. PubMed ID: 30950072
[TBL] [Abstract][Full Text] [Related]
6. Paired-agent imaging as a rapid
Torres VC; Hodge S; Levy JJ; Vaickus LJ; Chen EY; LeBouef M; Samkoe KS
Front Oncol; 2023; 13():1196517. PubMed ID: 37427140
[TBL] [Abstract][Full Text] [Related]
7. Effect of nonspecific binding of imaging agents to plasma protein in the paired-agent imaging for resection during surgery (PAIRS).
Xu X; Tichauer KM; Samkoe KS
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11219():. PubMed ID: 34121794
[TBL] [Abstract][Full Text] [Related]
8. Toxicity and Pharmacokinetic Profile for Single-Dose Injection of ABY-029: a Fluorescent Anti-EGFR Synthetic Affibody Molecule for Human Use.
Samkoe KS; Gunn JR; Marra K; Hull SM; Moodie KL; Feldwisch J; Strong TV; Draney DR; Hoopes PJ; Roberts DW; Paulsen K; Pogue BW
Mol Imaging Biol; 2017 Aug; 19(4):512-521. PubMed ID: 27909986
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative Detection of Micrometastases in Whole Excised Lymph Nodes Using Fluorescent Paired-Agent Imaging Principles: Identification of a Suitable Staining and Rinsing Protocol.
Li C; Torres VC; He Y; Xu X; Basheer Y; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
Mol Imaging Biol; 2021 Aug; 23(4):537-549. PubMed ID: 33591478
[TBL] [Abstract][Full Text] [Related]
10. Dual-agent fluorescent labeling of soft-tissue sarcomas improves the contrast based upon targeting both interstitial and cellular components of the tumor milieu.
Sardar HS; Zai Q; Xu X; Gunn JR; Pogue BW; Paulsen KD; Henderson ER; Samkoe KS
J Surg Oncol; 2020 Dec; 122(8):1711-1720. PubMed ID: 32885452
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous extracellular and intracellular quantification of EGFR using paired-agent imaging in an
Samkoe KS; Schultz E; Solanki A; Wang L; Korber J; Tichauer KM; Gibbs SL
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10859():. PubMed ID: 32296254
[TBL] [Abstract][Full Text] [Related]
12. Quantifying Imaging Agent Binding and Dissociation in 3-D Cancer Spheroid Tissue Culture Using Paired-Agent Principles.
Li C; Rounds CC; Torres VC; He Y; Xu X; Papavasiliou G; Samkoe KS; Brankov JG; Tichauer KM
Ann Biomed Eng; 2024 Jun; 52(6):1625-1637. PubMed ID: 38409434
[TBL] [Abstract][Full Text] [Related]
13. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on the Phase 0 clinical trial of microdose administration of ABY-029 for fluorescence guided surgery: Stability testing.
Samkoe KS; Hull S; Elliott J; Sardar HS; Gunn J; Linos K; Tafe L; Harris B; Feldwisch J; Pogue BW; Roberts D; Henderson E; Paydarfar J; Paulsen K
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11222():. PubMed ID: 36051445
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens.
Chen Y; Streeter SS; Hunt B; Sardar HS; Gunn JR; Tafe LJ; Paydarfar JA; Pogue BW; Paulsen KD; Samkoe KS
Front Med Technol; 2023; 5():1009638. PubMed ID: 36875185
[TBL] [Abstract][Full Text] [Related]
16. Quantitative pharmacokinetic and biodistribution studies for fluorescent imaging agents.
Feng Y; Pannem S; Hodge S; Rounds C; Tichauer KM; Paulsen KD; Samkoe KS
Biomed Opt Express; 2024 Mar; 15(3):1861-1877. PubMed ID: 38495714
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
18. Measuring microdose ABY-029 fluorescence signal in a primary human soft-tissue sarcoma resection.
Samkoe KS; Sardar HS; Gunn J; Feldwisch J; Linos K; Henderson E; Pogue B; Paulsen K
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10862():. PubMed ID: 31595101
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
